Ab locks for improving the selectivity and safety of antibody drugs
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Biomedical Science"
DOI: 10.1186/s12929-020-00652-z
Abstract: Monoclonal antibodies (mAbs) are a major targeted therapy for malignancies, infectious diseases, autoimmune diseases, transplant rejection and chronic inflammatory diseases due to their antigen specificity and longer half-life than conventional drugs. However, long-term systemic antigen… read more here.
Keywords: selectivity safety; improving selectivity; safety antibody; locks improving ... See more keywords